Friday, 23 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Drug
Roche Advances Prasinezumab to Phase III for Early Parkinson’s Disease
June 17, 2025
Company
Deals
Simcere and NextCure Forge Strategic Alliance to Co-Develop SIM0505 ADC for Solid Tumors
June 17, 2025
Company
AstraZeneca’s Oncology Executive Michael Lai to Leave Company in June
June 24, 2025
Company
Deals
Eli Lilly Close to Acquiring Verve Therapeutics for Up to USD 1.3 Billion
June 17, 2025
Company
Drug
Pediatrix Therapeutics Wins Macau Approval for Neffy Epinephrine Nasal Spray
June 17, 2025
Company
Drug
Minova Pharmaceuticals Launches Rongzhi, China’s First Injectable Adipocytolytic Drug
June 17, 2025
Legal / IP
RemeGen Secures 1,827-Day Patent Extension for Telitacicept in China
June 17, 2025
Company
Drug
Fujian Cosunter Gains Ethics Approval for Phase III Study of Neracorvir in CHB Patients
June 17, 2025
Company
Drug
CDE Accepts NDA for Ark Bio’s Azstarys, a Priority-Reviewed ADHD Treatment
June 17, 2025
Company
Drug
Ascentage Pharma Highlights Hematology Advances at EHA 2025, Focus on Olverembatinib and APG-5918
June 17, 2025
Company
Deals
Clover Biopharmaceuticals Terminates Adimmune Influenza Vaccine Pact Over Market Shifts
June 17, 2025
Company
Drug
Fosun Pharma’s Serplulimab Approved in Singapore and Malaysia for ES-SCLC Treatment
June 17, 2025
1
2
…
12
13
14
15
16
…
27
28
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
